Rybelsus® (semaglutide) is a prescription medication approved by the FDA for managing type 2 diabetes in adults. This drug is part of a group called GLP-1 receptor agonists, which work by imitating the incretin hormone GLP-1. This helps to increase insulin release after eating, lower glucagon levels, and slow down the emptying of the stomach, all of which contribute to improved blood sugar levels. Semaglutide helps to reduce appetite by making patients feel fuller, faster.

Cyanocobalamin is used to treat or prevent vitamin B12 deficiency caused by dietary deficiencies, certain types of anemias, pregnancy, and other disease states. Cyanocobalamin injections for maintenance therapy are conveniently dosed just once a month and are injected into the muscle or deep under the skin.

Approved on November 8th, 2023, Zepbound is an injectable prescription medication used to help reduce weight for adults that struggle keeping it off. It is indicated for individuals who are overweight, obese, or have medical conditions causing excessive weight gain. It is injected under the skin once weekly and may be increased based on clinical response and tolerance. Follow package instructions upon receiving the product. *This product is not eligible for discount*

Metformin is a medication used to help lower blood sugar for Type 2 diabetes, typically in addition to lifestyle intervention of diet and exercise.  

Metformin is a medication used to help lower blood sugar for Type 2 diabetes, typically in addition to lifestyle intervention of diet and exercise.  

Wegovy is used for chronic weight management in individuals with a BMI of > 30 kg/m2, or a BMI of > 27 kg/m2 and weight associated comorbidities, including high cholesterol, diabetes, and high blood pressure. Wegovy is injected under the skin once weekly with a total duration of therapy of up to 16 weeks. Therapy can be discontinued soon if desirable results are achieved. Follow package instructions upon receiving the product. *This product is not eligible for discount*

Ozempic® (semaglutide) is a once-weekly injectable medication used to improve blood sugar control in adults with type 2 diabetes and to reduce the risk of major cardiovascular events such as heart attack or stroke in people with both type 2 diabetes and known heart disease. It belongs to a class of drugs known as GLP-1 receptor agonists, which work by mimicking a natural hormone that stimulates insulin release, reduces the amount of sugar produced by the liver, and slows down digestion to help with appetite control. Ozempic® may also lead to weight loss, making it a beneficial option for people managing both diabetes and obesity. 

Mounjaro is used to treat type 2 diabetes alone or in combination with other medications. Mounjaro is injected under the skin once weekly and may be increased based on clinical response and tolerance. Follow package instructions upon receiving the product. *This product is not eligible for discount*